| Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia M Kanda, H Matthaei, J Wu, SM Hong, J Yu, M Borges, RH Hruban, ... Gastroenterology 142 (4), 730-733. e9, 2012 | 834 | 2012 |
| ATM Mutations in Patients with Hereditary Pancreatic Cancer NJ Roberts, Y Jiao, J Yu, L Kopelovich, GM Petersen, ML Bondy, ... Cancer discovery 2 (1), 41-46, 2012 | 580 | 2012 |
| MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance T Moriyama, K Ohuchida, K Mizumoto, J Yu, N Sato, T Nabae, S Takahata, ... Molecular cancer therapeutics 8 (5), 1067-1074, 2009 | 413 | 2009 |
| Deleterious germline mutations in patients with apparently sporadic pancreatic adenocarcinoma K Shindo, J Yu, M Suenaga, S Fesharakizadeh, C Cho, A Macgregor-Das, ... Journal of Clinical Oncology 35 (30), 3382-3390, 2017 | 410 | 2017 |
| Survival in locally advanced pancreatic cancer after neoadjuvant therapy and surgical resection G Gemenetzis, VP Groot, AB Blair, DA Laheru, L Zheng, AK Narang, ... Annals of surgery 270 (2), 340-347, 2019 | 361 | 2019 |
| Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas E Amato, M Molin, A Mafficini, J Yu, G Malleo, B Rusev, M Fassan, ... The Journal of pathology 233 (3), 217-227, 2014 | 351 | 2014 |
| MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls A Li, J Yu, H Kim, CL Wolfgang, MI Canto, RH Hruban, M Goggins Clinical cancer research 19 (13), 3600-3610, 2013 | 343 | 2013 |
| The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ... Nature 486 (7402), 266-270, 2012 | 341 | 2012 |
| MicroRNA alterations of pancreatic intraepithelial neoplasias J Yu, A Li, SM Hong, RH Hruban, M Goggins Clinical cancer research 18 (4), 981-992, 2012 | 281 | 2012 |
| Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma VP Groot, G Gemenetzis, AB Blair, RJ Rivero-Soto, J Yu, AA Javed, ... Annals of surgery 269 (6), 1154-1162, 2019 | 273 | 2019 |
| MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell … J Yu, K Ohuchida, K Mizumoto, N Sato, T Kayashima, H Fujita, K Nakata, ... Molecular cancer 9, 1-10, 2010 | 242 | 2010 |
| Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins Gut 64 (11), 1783-1789, 2015 | 229 | 2015 |
| Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy H Fujita, K Ohuchida, K Mizumoto, S Itaba, T Ito, K Nakata, J Yu, ... Neoplasia 12 (10), 807-IN8, 2010 | 190 | 2010 |
| International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis AJ Scott, JL Alexander, CA Merrifield, D Cunningham, C Jobin, R Brown, ... Gut 68 (9), 1624-1632, 2019 | 173 | 2019 |
| Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal … J Yu, Y Sadakari, K Shindo, M Suenaga, A Brant, JAN Almario, M Borges, ... Gut 66 (9), 1677-1687, 2017 | 163 | 2017 |
| Genetic analyses of isolated high‐grade pancreatic intraepithelial neoplasia (HG‐PanIN) reveal paucity of alterations in TP53 and SMAD4 W Hosoda, P Chianchiano, JF Griffin, ME Pittman, LAA Brosens, M Noë, ... The Journal of pathology 242 (1), 16-23, 2017 | 151 | 2017 |
| MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion J Yu, K Ohuchida, K Mizumoto, H Fujita, K Nakata, M Tanaka Cancer biology & therapy 10 (8), 748-757, 2010 | 147 | 2010 |
| Down-regulation of deoxycytidine kinase enhances acquired resistance to gemcitabine in pancreatic cancer S Ohhashi, K Ohuchida, K Mizumoto, H Fujita, T Egami, J Yu, H Toma, ... Anticancer research 28 (4B), 2205-2212, 2008 | 147 | 2008 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 146 | 2019 |
| Circulating tumor cells dynamics in pancreatic adenocarcinoma correlate with disease status: results of the prospective CLUSTER study G Gemenetzis, VP Groot, J Yu, D Ding, JA Teinor, AA Javed, LD Wood, ... Annals of surgery 268 (3), 408-420, 2018 | 145 | 2018 |
Christopher L.WolfgangNYU Grossman School of Medicine在 NYULangone.org 的电子邮件经过验证
